Crossmark

Deoxyhypusine synthase deficiency syndrome zebrafish model: aberrant morphology, epileptiform activity, and reduced arborization of inhibitory interneurons

Crossref DOI link: https://doi.org/10.1186/s13041-024-01139-w

Published Online: 2024-09-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shojaeinia, Elham

Mastracci, Teresa L.

Soliman, Remon

Devinsky, Orrin

Esguerra, Camila V.

Crawford, Alexander D.
License Information

Text and Data Mining valid from 2024-09-27

Version of Record valid from 2024-09-27
More Information

Article History

Received: 27 May 2024

Accepted: 3 September 2024

First Online: 27 September 2024

Declarations

:

: The experiments were approved by Mattilsynet (Norwegian Food Safety Authority, FOTS ID 23935, Modeling severe neurological disorders in vivo for high-throughput drug discovery, valid from 01.07.2020 to 01.07.2024).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below